Pelikan Technologies is dedicated to the development of innovative hand-held diagnostic and monitoring devices capable of significantly improving the screening and management of a variety of medical conditions.

In addition to diabetes, the company’s versatile technology platform has applications across a range of other medical conditions that involve blood screening and monitoring. Point-of-care testing and diagnostic panel test systems also represent markets that can benefit from Pelikan’s novel technology.

The Pelikan Sun can significantly improve the quality of life for people with diabetes by combining several of the company’s proprietary technologies into the most convenient and effective blood glucose self-monitoring device available. Pelikan’s line of diabetes management tools will address the pain and inconvenience that has stymied the industry’s manufacturers, and plagued people with diabetes, contributing to poor blood glucose monitoring compliance. By targeting these barr


Date Type Amount Investors Valuation
09/30/07 Series E 69M Clarus Ventures, HBM Bioventures, Heidelberg Innovation, Lombard Odier, Mannheim LLC, swissfirst Bank Unknown


Gerhard Ruehl (GM PTG / Head of European Distribution)

Norbert Bartetzko (GM PTG / Managing Director)

Glenn Moeller (Board Member)

Martin Bussmann (Board Member)

Dennert Ware (Board Member)

View more details about all 12 people at Pelikan Technologies